Merck KGaA, Darmstadt, Germany, Announces Collaboration With Iktos for Generative Artificial Intelligence (AI) Technology
- Collaboration agreement enables Merck KGaA, Darmstadt,?Germany, access to Iktos AI technology across three drug discovery projects
- Generative modelling AI technology enables rapid and cost-effective design of novel drugs
- Agreement is part of Merck KGaA, Darmstadt,?Germany's?R&D strategy to advance drug discovery with strategic technology-focused collaborations
Media Relations?
gangolf.schrimpf@emdgroup.com?
Phone: +49-6151-72-9591?
Investor Relations?
investor.relations@emdgroup.com?
Phone: +49-6151-72-3321 SOURCE Merck